PharmaBoardroom

Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a…

Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of…

The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you…

The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in…

Javier Anitua, Managing Director of Mylan Spain, discusses the preservation of Spain’s pharmacy model, preventive solutions for pharmacists, and the…

“Clinica Alemana’s objective is to be the most patient-centric clinic and we take that very seriously. Therefore, we constantly strive to provide…

Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses…

“Although Pfizer is today one of the major contributors to Investigator-Initiated Research in Portugal in very important areas like inflammation,…

José Aranda da Silva, General Manager of Formifarma Portugal, stresses the importance of market access, demonstrating added value for companies…

Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote…

Riaz Bandali, President ESD of InVentiv Health Clinical discusses the ways in which the company’s unique combination of different technologies and…

With budget cuts in response to the financial crisis barely touching the science sector, could it be that innovative pharmaceutical companies could…